Tranexamic Acid Reduces Blood Transfusion Needs During Major Surgeries Without Increasing Clotting Risks

A clinical trial published in the *New England Journal of Medicine* indicates that the drug tranexamic acid reduces the need for blood transfusions during major surgeries without increasing the risk of blood clots. Researchers from the University of Manitoba and The Ottawa Hospital coordinated the study, which evaluated the medication’s impact on patient outcomes across a variety of surgical procedures.

The study findings suggest that the inexpensive medication effectively manages bleeding during complex operations. By analyzing data from the trial, the research team determined that patients who received the drug required fewer transfusions compared to those who did not. Furthermore, the clinical data showed no significant rise in the incidence of dangerous clotting events, addressing a primary safety concern associated with anti-fibrinolytic treatments. The researchers conducted the trial to assess whether the drug could serve as a standard intervention to improve surgical safety and reduce reliance on blood supplies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 10, 2026

Author

GOAI